As of Oct 21
| -0.11 / -1.57%|
The 8 analysts offering 12-month price forecasts for PTC Therapeutics Inc have a median target of 12.50, with a high estimate of 20.00 and a low estimate of 5.00. The median estimate represents a +80.90% increase from the last price of 6.91.
The current consensus among 9 polled investment analysts is to Hold stock in PTC Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.